[1]
“Risk factors of intestinal parasitic infections among human immunodeficiency virus‑infected patients on highly active antiretroviral therapy”, PHMJ, vol. 11, no. 1, pp. 15–20, Oct. 2016, doi: 10.60787/phmj.v11i1.59.